StockNews.AI

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC

StockNews.AI • 1 minute

MDYNHWQEW
High Materiality8/10

Information

TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) ann...

Original source

AI Summary

Venus Concept Inc. is voluntarily delisting its common stock from NASDAQ due to high compliance costs, with the last trading day expected on February 6, 2026. This strategic move aims to support its turnaround plan and reduce operational expenses, facilitating its long-term financial goals.

Sentiment Rationale

While delisting can typically spark fear of instability, the company's focus on cost-reduction strategies and maintained compliance suggests prudent management, similar to past successful turnarounds in other companies.

Trading Thesis

Consider buying VERO stock on potential recovery signals post-delist.

Market-Moving

  • Possible volatility around last trading day and investor sentiment shifts.
  • Cost savings could improve financial outlook, attracting new investors.
  • Announcement of continued partnership with Madryn Asset may stabilize stock.
  • Potential investor anxiety could depress short-term share prices.

Key Facts

  • Venus Concept to delist from NASDAQ amid compliance cost concerns.
  • Last trading day expected on February 6, 2026.
  • Delisting aims to support turnaround plan and reduce operational costs.
  • CEO Rajiv De Silva emphasizes long-term strategy with Madryn Asset Management.
  • Company still compliant with Nasdaq listing but prioritizes financial sustainability.

Companies Mentioned

  • Madryn Asset Management (N/A): Assisting Venus in turnaround strategy.
  • HealthQuest Capital (N/A): Investor possibly influencing strategic direction.
  • EW Healthcare Partners (N/A): Significant equity backer, indicating long-term stakes.

Corporate Developments

This falls under 'Corporate Developments' due to Venus Concept’s decision to delist and refocus on operational efficiency. It is a significant strategic shift impacting future growth and resource allocation.

Venus Concept (VERO) Announces Voluntary Delisting from Nasdaq

TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) — Venus Concept Inc. (NASDAQ: VERO) has officially announced its decision to voluntarily delist its common stock from the NASDAQ Capital Market and deregister its shares with the Securities and Exchange Commission (SEC). This strategic move comes as the Company assesses the resources required to maintain its reporting obligations and determines that these costs outweigh the benefits derived from the Nasdaq listing.

Details of the Delisting and Deregistration Process

Venus Concept has notified Nasdaq of its intention to delist and deregister its common stock. The Company plans to:

  • File a Form 25 (Notification of Removal from Listing) with the SEC around January 30, 2026.
  • Cease trading on Nasdaq with an expected last trading day of February 6, 2026.
  • File a Form 15 (Certification and Notice of Termination from Registration) with the SEC on or about February 9, 2026, which will suspend its obligation to file periodic reports such as Forms 10-K, 10-Q, and 8-K.

Implications for Shareholders and Company Strategy

The Board of Directors of Venus Concept, following a comprehensive evaluation, believes that this decision is in the best interests of the Company and its shareholders. Rajiv De Silva, Chief Executive Officer of Venus Concept, stated, "The reduced costs for compliance will help facilitate the Company's ability to continue to execute our turnaround plan." He further added that the Company will continue to collaborate with Madryn Asset Management to aim for sustained, long-term financial success.

About Venus Concept

Venus Concept is a leader in global medical aesthetic technology, boasting a diverse product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies available in over 60 countries and 9 direct markets. The Company's product offerings include:

  • Venus NOVA
  • Venus Versa
  • Venus Bliss
  • Venus Viva
  • NeoGraft® and ARTAS iX® Robotic Hair Restoration systems

Venus Concept is supported by prominent healthcare industry growth equity investors like EW Healthcare Partners, HealthQuest Capital, and Madryn Asset Management, L.P.

Forward-Looking Statements

This announcement includes forward-looking statements as defined under federal securities laws. Such statements are inherently subject to risks and uncertainties that may affect future performance and results. It is crucial for investors to consider these risks while evaluating Venus Concept's (VERO) future outlook, particularly regarding the impacts of the delisting and deregistration on the company's operations and financial stability. For more detailed risk factors, please refer to the Company’s annual and quarterly reports filed with the SEC.

Related News